Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
20/05 | 5,620 USD
-1,06% |
-1,06% |
C4X Discovery Holdings plc |
25/04 | 12,000 GBX
+27,32% |
+27,32% |
|
Cabaletta Bio Inc |
20/05 | 12,880 USD
+4,29% |
+4,29% |
|
Calithera Biosciences Inc |
20/05 | 0,020 USD
0,00% |
0,00% |
|
Calliditas Therapeutics AB |
20/05 | 22,000 USD
-0,86% |
-0,86% |
|
Cambridge Cognition Holdings plc |
20/05 | 45,000 GBX
0,00% |
0,00% |
|
Can B Corp |
20/05 | 0,025 USD
+6,52% |
+6,52% |
|
Can-Fite Biopharma Ltd |
20/05 | 2,465 USD
+3,57% |
+3,57% |
|
Capricor Therapeutics Inc |
20/05 | 6,300 USD
+1,61% |
+1,61% |
|
Cara Therapeutics Inc |
20/05 | 0,750 USD
0,00% |
0,00% |
Carbios |
20/05 | 23,000 EUR
+0,44% |
+0,44% |
Cardiol Therapeutics Inc - Class A |
17/05 | 2,930 CAD
-9,01% |
-9,01% |
|
Cardiovascular Systems Inc. |
27/04 | 20,000 USD
+0,15% |
+0,15% |
|
Caredx Inc |
20/05 | 15,630 USD
+0,84% |
+0,84% |
|
Carisma Therapeutics, Inc. |
20/05 | 1,410 USD
0,00% |
0,00% |
|
Carmat |
20/05 | 3,040 EUR
-1,78% |
-1,78% |
|
CASI Pharmaceuticals Inc |
20/05 | 3,130 USD
-5,15% |
-5,15% |
|
Cassava Sciences Inc |
20/05 | 22,095 USD
-4,43% |
-4,43% |
|
Castle Biosciences Inc |
20/05 | 24,940 USD
+2,89% |
+2,89% |
|
Catalent Inc. |
20/05 | 55,000 USD
-0,67% |
-0,67% |
|
Catalyst Biosciences Inc |
30/10 | 0,511 USD
-2,65% |
-2,65% |
|
Catalyst Pharmaceuticals Inc |
20/05 | 16,920 USD
+2,61% |
+2,61% |
|
Ceapro Inc. |
17/05 | 0,270 CAD
-6,90% |
-6,90% |
|
Cel-Sci Corp. |
20/05 | 1,260 USD
-0,79% |
-0,79% |
|
Celldex Therapeutics Inc. |
20/05 | 37,750 USD
-1,20% |
-1,20% |
|
Cellectar Biosciences Inc |
20/05 | 3,160 USD
-4,24% |
-4,24% |
|
Cellectis |
20/05 | 2,660 EUR
+0,57% |
+0,57% |
|
Cellectis |
20/05 | 2,970 USD
-0,67% |
-0,67% |
|
Celyad Oncology |
20/07 | 0,524 USD
-5,42% |
-5,42% |
Celyad Oncology |
20/05 | 0,318 EUR
+1,44% |
+1,44% |
|
Cerus Corp. |
20/05 | 1,950 USD
-1,02% |
-1,02% |
|
Champions Oncology Inc |
20/05 | 4,760 USD
+1,28% |
+1,28% |
|
Charlottes Web Holdings Inc |
17/05 | 0,250 CAD
+8,70% |
+8,70% |
|
Check-Cap Ltd |
20/05 | 2,180 USD
-0,23% |
-0,23% |
|
Checkpoint Therapeutics Inc |
20/05 | 2,030 USD
+7,98% |
+7,98% |
|
Chembio Diagnostics Inc. |
27/04 | 0,455 USD
+0,22% |
+0,22% |
|
Chimerix Inc |
20/05 | 0,986 USD
-0,18% |
-0,18% |
|
China Pharma Holdings Inc. |
20/05 | 0,357 USD
+8,87% |
+8,87% |
|
China SXT Pharmaceuticals Inc |
20/05 | 1,210 USD
+5,22% |
+5,22% |
|
Chinook Therapeutics Inc |
10/08 | 40,390 USD
+0,22% |
+0,22% |
|
Cidara Therapeutics Inc |
20/05 | 11,260 USD
+0,45% |
+0,45% |
|
Cipher Pharmaceuticals Inc |
17/05 | 8,690 CAD
-1,47% |
-1,47% |
|
Citius Pharmaceuticals Inc |
20/05 | 0,660 USD
+1,76% |
+1,76% |
|
Clean Air Metals Inc |
17/05 | 0,055 CAD
+10,00% |
+10,00% |
|
ClearPoint Neuro Inc |
20/05 | 6,130 USD
-1,13% |
-1,13% |
|
Clearside Biomedical Inc |
20/05 | 1,330 USD
+1,53% |
+1,53% |
|
Clovis Oncology Inc |
21/02 | 0,090 USD
+18,42% |
+18,42% |
|
Cns Pharmaceuticals Inc |
20/05 | 0,216 USD
-0,46% |
-0,46% |
|
Co-Diagnostics Inc |
20/05 | 1,100 USD
+0,92% |
+0,92% |
|
Cocrystal Pharma Inc |
20/05 | 1,900 USD
-2,56% |
-2,56% |
|
Codiak Biosciences Inc |
13/05 | 0,057 USD
0,00% |
0,00% |
|
Cogent Biosciences Inc |
20/05 | 7,840 USD
+5,38% |
+5,38% |
|
CohBar Inc |
20/05 | 1,000 USD
+13,62% |
+13,62% |
|
Coherus Biosciences Inc |
20/05 | 2,080 USD
-1,89% |
-1,89% |
|
Collegium Pharmaceutical Inc |
20/05 | 34,150 USD
+5,17% |
+5,17% |
|
CollPlant Biotechnologies Ltd |
20/05 | 6,190 USD
-2,37% |
-2,37% |
Coloplast |
17/05 | 850,000 DKK
+1,07% |
+1,07% |
|
Compass Pathways Plc |
20/05 | 7,920 USD
+1,02% |
+1,02% |
|
Compass Therapeutics Inc |
20/05 | 1,600 USD
0,00% |
0,00% |
|
Compugen Ltd. |
20/05 | 1,740 USD
-17,54% |
-17,54% |
|
Concert Pharmaceuticals Inc |
13/05 | 8,370 USD
0,00% |
0,00% |
|
Condor Technologies |
29/02 | 12,000 EUR
-4,00% |
-4,00% |
|
Conformis Inc. |
1/09 | 2,260 USD
0,00% |
0,00% |
|
Conmed Corp. |
20/05 | 75,310 USD
+0,79% |
+0,79% |
|
ContraFect Corp |
6/02 | 0,033 USD
+8,73% |
+8,73% |
|
Convatec Group |
20/05 | 254,400 GBX
-0,08% |
-0,08% |
|
Cooper Companies, Inc. |
20/05 | 97,210 USD
-0,10% |
-0,10% |
|
Cooper Companies, Inc. |
20/05 | 97,210 USD
-0,10% |
-0,10% |
|
Corbus Pharmaceuticals Holdings Inc |
20/05 | 48,550 USD
+7,89% |
+7,89% |
|
Corcept Therapeutics Inc |
20/05 | 28,880 USD
+2,81% |
+2,81% |
|
CorMedix Inc |
20/05 | 5,050 USD
-1,37% |
-1,37% |
|
Corvus Pharmaceuticals Inc |
20/05 | 2,280 USD
-0,44% |
-0,44% |
|
Covalon Technologies Ltd. |
16/05 | 1,090 CAD
-1,80% |
-1,80% |
|
Creo Medical Group Plc |
20/05 | 36,500 GBX
+3,40% |
+3,40% |
|
Crescita Therapeutics Inc |
17/05 | 0,475 CAD
+10,47% |
+10,47% |
|
Crinetics Pharmaceuticals Inc |
20/05 | 50,620 USD
-1,52% |
-1,52% |
|
CRISPR Therapeutics AG |
20/05 | 55,470 USD
-1,33% |
-1,33% |
|
Cronos Group Inc |
20/05 | 2,780 USD
-4,14% |
-4,14% |
|
Crossject |
20/05 | 1,970 EUR
+1,03% |
+1,03% |
|
Cryo-Cell International, Inc. |
20/05 | 8,940 USD
-0,67% |
-0,67% |
|
CTI BioPharma Corp |
23/06 | 9,090 USD
0,00% |
0,00% |
|
Cue Biopharma Inc |
20/05 | 1,870 USD
+9,36% |
+9,36% |
|
Cumberland Pharmaceuticals Inc. |
20/05 | 1,560 USD
+3,31% |
+3,31% |
|
CureVac N.V. |
20/05 | 3,400 USD
-2,58% |
-2,58% |
|
Curis Inc |
20/05 | 10,520 USD
-10,85% |
-10,85% |
|
Cutera Inc |
20/05 | 2,260 USD
+1,80% |
+1,80% |
|
Cyanotech Corp. |
20/05 | 0,350 USD
+16,67% |
+16,67% |
|
Cyclacel Pharmaceuticals Inc |
20/05 | 6,990 USD
+14,03% |
+14,03% |
|
Cyclacel Pharmaceuticals Inc |
20/05 | 2,180 USD
-4,80% |
-4,80% |
|
Cyclerion Therapeutics Inc |
20/05 | 2,798 USD
-1,82% |
-1,82% |
|
Cymabay Therapeutics Inc |
21/03 | 32,480 USD
+0,03% |
+0,03% |
|
Cytokinetics Inc |
20/05 | 60,600 USD
+1,80% |
+1,80% |
|
CytomX Therapeutics Inc |
20/05 | 1,920 USD
+1,59% |
+1,59% |
|
Cytosorbents Corp |
20/05 | 0,979 USD
+1,22% |
+1,22% |
Cytotools AG |
20/05 | 0,500 EUR
0,00% |
0,00% |